DocMe

DocMe is a UK-based health tech startup, founded in 2020 with a mission to empower people to live longer, healthier lives. The company's slogan, "We empower people to live longer life healthily," encapsulates its core vision, focusing on preventative measures and empowering individuals to manage lifestyle diseases. DocMe has gained recognition from InnovateUK for its pioneering technology, which allows users to measure their blood pressure through a simple 30-second facial video, without the need for GP visits. The startup's innovative approach to decentralised healthcare aims to address the global challenge of hypertension, which affects almost one-third of adults worldwide. DocMe's technology provides users with actionable insights and trend analyses to confront cardiovascular threats effectively. The company also offers healthcare professionals advanced trend analytics for early detection of potential health concerns, marking a significant leap from conventional procedures. In April 2021, DocMe secured a $250.00K Seed Round investment from Newchip Accelerator, signaling investor confidence in the startup's vision and technological capabilities. With a focus on tapping into the global wellness market, which amounts to a substantial $1.5 trillion, DocMe is poised to significantly impact the health insurance and healthcare industries. The startup's commitment to championing healthy aging and empowering individuals through awareness aligns with the growing demand for personalized, user-friendly, and instantly available healthcare solutions.